$29 Million is the total value of Pharmstandard International S.A.'s 7 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALNA | Sell | Allena Pharmaceuticals | $9,376,000 | -18.1% | 873,031 | -0.6% | 32.28% | -29.7% |
| PTGX | Protagonist Therapeutics, Inc. | $7,724,000 | +53.1% | 750,632 | 0.0% | 26.59% | +31.4% | |
| NTGN | New | Neon Therapeutics Inc. | $5,027,000 | – | 588,611 | +100.0% | 17.31% | – |
| JNCE | Jounce Therapeutics, Inc. | $3,673,000 | -15.1% | 565,063 | 0.0% | 12.65% | -27.2% | |
| PRTO | Proteon Therapeutics Inc. | $3,135,000 | -20.4% | 1,607,807 | 0.0% | 10.79% | -31.7% | |
| ARGS | Argos Therapeutics Inc. | $83,000 | -39.0% | 826,153 | 0.0% | 0.29% | -47.6% | |
| ARGS | Argos Therapeutics Inc.call | $26,000 | -38.1% | 256,030 | 0.0% | 0.09% | -46.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Joint Stock Co Pharmstandard #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Protagonist Therapeutics, Inc. | 8 | Q3 2018 | 50.6% |
| Argos Therapeutics Inc. | 8 | Q3 2018 | 55.9% |
| Proteon Therapeutics Inc. | 8 | Q3 2018 | 15.8% |
| Argos Therapeutics Inc. | 8 | Q3 2018 | 23.6% |
| Jounce Therapeutics, Inc. | 7 | Q3 2018 | 38.8% |
| Allena Pharmaceuticals | 4 | Q3 2018 | 45.9% |
| Neon Therapeutics Inc. | 1 | Q3 2018 | 17.3% |
View Pharmstandard International S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Allena Pharmaceuticals, Inc. | November 15, 2018 | 873,031 | 4.2% |
| Protagonist Therapeutics, Inc | February 21, 2018 | 982,270 | 4.8% |
| ARGOS THERAPEUTICS INC | June 26, 2017 | 18,362,883 | 39.9% |
| PROTEON THERAPEUTICS INC | February 12, 2015 | 1,165,344 | 7.1% |
View Pharmstandard International S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-11-15 |
| SC 13G | 2018-11-15 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| SC 13G/A | 2018-02-21 |
| SC 13G | 2018-02-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-03 |
| 4 | 2017-11-02 |
| 13F-HR/A | 2017-08-17 |
View Pharmstandard International S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.